查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1965387

白色生技市场－全球产业规模、份额、趋势、机会、预测：按产品、应用、地区和竞争对手划分，2021-2031年

White Biotechnology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 181 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球白色生物技术市场预计将从 2025 年的 2,625.4 亿美元成长到 2031 年的 4,498.4 亿美元，复合年增长率为 9.39%。

在这个领域，生物系统（例如酵素和微生物）被用于生产从化学品和材料到生质燃料等各种生物基产品。推动该市场发展的关键因素包括对永续工业实践日益增长的需求，以及旨在减少对石化燃料依赖的严格环境法规。例如，欧洲生质塑胶协会报告称，到2024年，全球生质塑胶产能将达到约247万吨，这反映了该产业的规模。

市场概览
预测期 2027-2031
市场规模：2025年 2625.4亿美元
市场规模：2031年 4498.4亿美元
复合年增长率：2026-2031年 9.39%
成长最快的细分市场 生质燃料
最大的市场 北美洲

白色生物技术领域广泛发展的一大障碍是其生产成本高于传统石油化学製程。这种经济差距阻碍了寻求更环保技术的企业进入市场，并常常限制了生物基解决方案在价格敏感型市场的扩充性应用。因此，与成熟方法相比，经济劣势仍然是其广泛应用的一大挑战。

市场驱动因素

政府对可再生化学品生产的奖励和补贴是推动白色生物技术市场发展的主要动力，因为它能降低生物基基础设施扩张带来的财务风险。诸如津贴和贷款担保之类的机制对于应对高昂的资本成本往往阻碍实验室研究向商业化生产过渡的挑战至关重要。透过降低投资风险，世界各国政府正加速加强国内生物经济供应链，并推动经济多元化，摆脱对石化产品的依赖。例如，2024年10月，BioMADE在一份题为「BioMADE投资2,690万美元用于17个计划」的新闻稿中宣布，已拨款支持国内生物产业製造创新规模化发展。这将使企业能够建造试点设施并优化发酵製程。

同时，合成生物学和酵素工程的进步正在透过提高微生物细胞工厂的效率和产量来改变市场模式。人工智慧驱动的优化和精准的基因重编程使研究人员能够设计出将原材料转化为高价值化学品的微生物，其转化率极高，且具有显着的特异性，与传统萃取方法相比，单位成本显着降低。这项技术的成熟正在推动其在从家居用品到农业等各行业的快速商业性化应用。例如，Novonesys公司在2025年2月发布的「公司公告3」中报告称，其2024年的有机销售额增长了8%，证实了工业领域的强劲需求增长。此外，白宫在2024年指出，自该倡议启动以来，联邦政策已推动公共和私人生物製造领域的投资总额达到460亿美元。

市场挑战

与成熟的石油化学方法相比，更高的生产成本是白色生物技术市场面临的主要结构性障碍。生物基生产流程需要对先进的发酵技术、纯化系统和专用原料供应链进行大量资本投资，所有这些都会增加营运成本。与受益于数十年优化基础设施和大规模经济规模的石油化学产业不同，白色生物技术公司往往面临高昂的单位成本，这降低了最终产品在全球价格敏感型市场中的竞争力。

这种经济差距直接限制了生物基解决方案的扩充性，尤其是在利润率较低的领域，例如工业材料和通用化学品。当价格溢价威胁到盈利时，製造商往往会犹豫是否要全面转型为环保替代品，导致市场渗透速度放缓。根据世界生质能源协会预测，到2024年，全球乙醇产量将达到1,180亿公升。虽然这无疑是一个庞大的数字，但持续存在的成本限製表明，要实现完全替代现有石化燃料衍生产品所需的巨大产量仍然充满挑战。

市场趋势

酵素法解决方案在塑胶回收再利用和增值回收的兴起，标誌着白色生物技术市场的一个重要转折点，它克服了机械方面的限制，实现了材料的无限循环利用。先进的酵素法製程能够将PET和尼龙等复杂塑胶分解成原生级单体，这些单体可以重新投入生产循环，且性能不会劣化。这项技术满足了业界对高品质再生材料的关键需求，同时减少了环境污染。为了体现这项技术的商业性势头，Samsara Eco在2024年6月发布的新闻稿《Samsara Eco完成A+轮融资1亿美元，致力于终结塑胶废弃物》中宣布，已筹集约6500万美元，用于加速酶法回收技术的部署，并在东南亚建设新的生产设施。

同时，市场正转向非食品生物质和废弃物衍生原料，这使得化学品生产与食品供应链脱钩。製造商越来越多地使用农业残余物和工业废气作为主要原料，从而减少碳足迹并降低与经济作物相关的价格波动风险。这种转变得益于气体发酵技术，该技术可以将碳排放转化为有价值的中间体，例如永续燃料和乙醇。以LanzaTec为例，该公司在2024年8月发布的2024年第二季财报中报告称，其收入增长了35%，达到1740万美元，这主要得益于其碳回收和生物炼製业务的扩张，这体现了废弃物变废为宝工艺日益增长的经济可行性。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球白色生物技术市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 依产品类型（生质燃料、生物质、生质聚合物）
    • 依应用领域（生质能源、食品和饲料添加剂、医药原料、个人护理和家居用品、其他）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美白色生物技术市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲白色生物技术市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区白色生物技术市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲白色生物技术市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲白色生物技术市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球白色生物技术市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Novozymes A/S
  • Kaneka Corporation
  • AngelYeast Co., Ltd.
  • Koninklijke DSM NV
  • Akzo Nobel NV
  • BASF SE
  • Henkel AG & Co. KGaA
  • Mitsubishi Corporation
  • DuPont de Nemours, Inc.
  • Amyris, Inc.

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 24289

The Global White Biotechnology Market is projected to expand from USD 262.54 Billion in 2025 to USD 449.84 Billion by 2031, reflecting a compound annual growth rate (CAGR) of 9.39%. This sector involves utilizing biological systems, such as enzymes and microorganisms, to produce biobased goods ranging from chemicals and materials to biofuels. Key factors driving this market include the rising demand for sustainable industrial practices and stringent environmental regulations designed to decrease dependence on fossil fuels. Highlighting the scale of the industry, European Bioplastics reported that global bioplastics production capacity reached approximately 2.47 million tonnes in 2024.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 262.54 Billion
Market Size 2031USD 449.84 Billion
CAGR 2026-20319.39%
Fastest Growing SegmentBiofuels
Largest MarketNorth America

A significant obstacle hindering the broader growth of the white biotechnology sector is the elevated production cost relative to conventional petrochemical processes. This financial discrepancy often creates a barrier to entry for businesses attempting to adopt greener technologies and restricts the scalability of biobased solutions in price-sensitive markets. Consequently, the economic disadvantage compared to established methods remains a critical challenge for widespread adoption.

Market Driver

Government incentives and subsidies for renewable chemical production serve as a major catalyst for the white biotechnology market by alleviating the financial risks associated with expanding bio-based infrastructure. Mechanisms such as grants and loan guarantees are crucial for bridging the gap between laboratory research and commercial-scale manufacturing, a stage where high capital costs often impede progress. By de-risking these investments, governments are strengthening domestic bioeconomy supply chains and accelerating the shift away from petrochemical reliance. For instance, BioMADE announced in October 2024, in a press release titled 'BioMADE Announces $26.9 Million Invested in 17 Projects', that it allocated funds to support the scaling of domestic bioindustrial manufacturing innovations, enabling companies to build pilot facilities and optimize fermentation processes.

Simultaneously, advancements in synthetic biology and enzyme engineering are transforming the market by improving the efficiency and yield of microbial cell factories. Through AI-driven optimization and precise genetic reprogramming, researchers can design microorganisms to convert feedstocks into high-value chemicals with remarkable specificity, significantly reducing unit costs compared to traditional extraction methods. This technological maturation is driving rapid commercial adoption across various industries, from household care to agriculture. Highlighting this momentum, Novonesis reported in its February 2025 'Company Announcement no. 3' an 8% organic sales growth for 2024, underscoring strong industrial uptake. Furthermore, the White House noted in 2024 that federal policies have spurred a total of $46 billion in public and private biomanufacturing investments since the initiative began.

Market Challenge

The high cost of production relative to established petrochemical methods constitutes a major structural barrier for the white biotechnology market. Bio-based manufacturing processes generally require substantial capital for advanced fermentation technologies, purification systems, and specialized feedstock supply chains, all of which increase operational expenses. Unlike the petrochemical industry, which benefits from decades of optimized infrastructure and large economies of scale, white biotechnology firms often face higher unit costs that make their end products less competitive in price-sensitive global markets.

This economic disparity directly limits the scalability of biobased solutions, particularly in sectors with thin profit margins like industrial materials and commodity chemicals. Manufacturers are often hesitant to fully transition to greener alternatives when price premiums threaten profitability, effectively slowing the rate of market penetration. According to the World Bioenergy Association, global ethanol output reached 118 billion liters in 2024, a figure that, while significant, emphasizes the continued difficulty in achieving the massive volumes required to fully displace fossil-based incumbents due to these persistent cost constraints.

Market Trends

The rise of enzymatic solutions for plastic recycling and upcycling marks a pivotal shift in the white biotechnology market, overcoming mechanical limitations to enable infinite material circularity. Advanced enzymatic processes break down complex plastics such as PET and nylon into their virgin-grade monomers, permitting their reintroduction into manufacturing cycles without performance degradation. This capability meets the critical industry need for high-quality recycled content while reducing environmental pollution. Reflecting the commercial momentum of this technology, Samsara Eco announced in June 2024, in the release 'Samsara Eco secures $100M in Series A+ funding to help end plastic waste', that it raised roughly US$65 million to accelerate the deployment of its enzymatic recycling capabilities and build new facilities in Southeast Asia.

Concurrently, the market is moving toward non-food biomass and waste-based feedstocks, thereby decoupling chemical production from the food supply chain. Manufacturers are increasingly using agricultural residues and industrial off-gases as primary inputs, which lowers carbon footprints and avoids the volatility of commodity crop prices. This transition is enabled by gas fermentation technologies that transform carbon emissions into valuable intermediates like sustainable fuels and ethanol. Illustrating the growing economic viability of these waste-to-value pathways, LanzaTech reported in its August 2024 'Second-Quarter 2024 Financial Results' a 35% year-over-year revenue increase to $17.4 million, driven largely by the expansion of its carbon recycling and biorefining operations.

Key Market Players

  • Novozymes A/S
  • Kaneka Corporation
  • AngelYeast Co., Ltd.
  • Koninklijke DSM N.V.
  • Akzo Nobel N.V.
  • BASF SE
  • Henkel AG & Co. KGaA
  • Mitsubishi Corporation
  • DuPont de Nemours, Inc.
  • Amyris, Inc.

Report Scope

In this report, the Global White Biotechnology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

White Biotechnology Market, By Product

  • Biofuels
  • Biochemicals
  • Biopolymers

White Biotechnology Market, By Application

  • Bioenergy
  • Food & feed Additives
  • Pharmaceutical Ingredients
  • Personal Care & Household Products
  • Others

White Biotechnology Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global White Biotechnology Market.

Available Customizations:

Global White Biotechnology Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global White Biotechnology Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Biofuels, Biochemicals, Biopolymers)
    • 5.2.2. By Application (Bioenergy, Food & feed Additives, Pharmaceutical Ingredients, Personal Care & Household Products, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America White Biotechnology Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States White Biotechnology Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada White Biotechnology Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico White Biotechnology Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application

7. Europe White Biotechnology Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany White Biotechnology Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
    • 7.3.2. France White Biotechnology Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom White Biotechnology Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy White Biotechnology Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain White Biotechnology Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application

8. Asia Pacific White Biotechnology Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China White Biotechnology Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
    • 8.3.2. India White Biotechnology Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan White Biotechnology Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea White Biotechnology Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia White Biotechnology Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application

9. Middle East & Africa White Biotechnology Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia White Biotechnology Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE White Biotechnology Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa White Biotechnology Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application

10. South America White Biotechnology Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil White Biotechnology Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia White Biotechnology Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina White Biotechnology Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global White Biotechnology Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Novozymes A/S
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Kaneka Corporation
  • 15.3. AngelYeast Co., Ltd.
  • 15.4. Koninklijke DSM N.V.
  • 15.5. Akzo Nobel N.V.
  • 15.6. BASF SE
  • 15.7. Henkel AG & Co. KGaA
  • 15.8. Mitsubishi Corporation
  • 15.9. DuPont de Nemours, Inc.
  • 15.10. Amyris, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer